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Ischaemic preconditioningATP) and large conductance calcium-activated (mitoBKCa) potassium channels
have been proposed to regulate mitochondrial K+ inﬂux and matrix volume and to mediate cardiac
ischaemic preconditioning (IP). However, the speciﬁcity of the pharmacological agents used in these studies
and the mechanisms underlying their effects on IP remain controversial. Here we used increasing
concentrations of K+-ionophore (valinomycin) to stimulate respiration by rat liver and heartmitochondria in
the presence of the K+/H+ exchanger nigericin. This allowed rates of valinomycin-induced K+ inﬂux to be
determined whilst parallel measurements of light scattering (A520) and matrix volume (
3H2O and [
14C]-
sucrose) enabled rates of K+ inﬂux to be correlated with increases in matrix volume. Light scattering readily
detected an increase in K+ inﬂux of b5 nmol K+ min−1 per mg protein corresponding to b2% mitochondrial
matrix volume increase. In agreement with earlier data no light-scattering changes were observed in
response to any mitoKATP channel openers or blockers. However, the mitoBKCa opener NS1619 (10–50 µM)
did decrease light scattering slightly, but this was also seen in K+-free medium and was accompanied by
uncoupling. Contrary to prediction, the mitoBKCa blocker paxilline (10–50 µM) decreased rather than
increased light scattering, and it also slightly uncoupled respiration. Our data argue against the presence of
signiﬁcant activities of either the mitoKATP or the mitoBKCa channel in rat liver and heart mitochondria and
provide further evidence that preconditioning induced by pharmacological openers of these channels is
more likely to involve alternative mechanisms.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIt has been known for many years that the inner membrane of the
mitochondria contains an electrogenic mechanism for K+ entry (K+
channel) that works in opposition to a K+/H+ antiporter to pump K+ out
of the matrix. The relative activities of the two systems are thought to
play a key role in the regulation of matrix volume (see [1–3]).
However, the identity of these channels and transporters remains
uncertain since none has been puriﬁed sufﬁciently to allow sequen-
cing. Nor has genomic analysis revealed any plasma membrane K+
channel isoform or spliced variant with a mitochondrial targeting
sequence [4]. Rather the presence and properties of these K+ transportine serumalbumin; cromakalim,
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rap).
ll rights reserved.mechanisms have been surmised from their functional characterisa-
tion in isolated mitochondria or reconstituted proteoliposomes (see
[5,6]). Three mechanisms have been proposed for K+ entry. First, many
laboratories have presented evidence for an ATP-regulated K+ channel
(mitoKATP) similar to that found in the plasma membrane but with
different sensitivities to openers such as diazoxide, cromakalim,
pinacidil and nicorandil and inhibitors including glibencamide and 5-
hydroxydecanoate [4,7–10]. The use of these drugs has led to the
proposal that this channel plays an important role in ischaemic pre-
conditioning (IP) (see [4,11–14]). However, other studies have
questioned the existence of these channels and have implicated
non-speciﬁc effects of mitoKATP channel openers and blockers in their
ability to mimic and antagonise IP respectively [4,7–10].
A second channel that may mediate electrogenic K+ entry into the
mitochondria is the adenine nucleotide translocase (ANT). This is
proposed to occur when mitochondria are depleted of adenine
nucleotides [15,16] or when adenine nucleotides have been displaced
from the ANT by pyrophosphate (PPi), atractyloside or carboxyatrac-
tyloside [10,17,18]. Since micromolar [Ca2+] is a potent inhibitor of
mitochondrial pyrophosphatase [19] and causes matrix [PPi] to
increase [20], this provides a mechanism to explain the increase in
matrix volume seen in isolated mitochondria exposed to micromolar
Fig. 1. The effects of nigericin on light scattering and matrix volume of rat liver mitochondria. Liver mitochondria were incubated with continuous stirring at 2 mg protein/ml in the
sample and reference cuvette of a split-beam spectrophotometer as described under Materials and methods. The medium contained 50 mM KCl (panel A) or either 125 mM KCl or
50 mM KCl (panel B) and was supplemented with 5 mM succinate plus 200 nM rotenone and 1 µM oligomycin. Where indicated, nigericin was added to the sample cuvette at the
concentration shown. In the experiment shown in panel B, 15 µl of buffer containing the required amounts of 3H2O and [14C]-sucrose was added to both cuvettes at the end of the run
(indicated as isotope). Four 0.8 ml samples were rapidly taken from each cuvette to pellet themitochondria by centrifugation and to determine the matrix volume as described under
Materials andmethods. For the experiment shown, which is a representative of three similar experiments on separate mitochondrial preparations, the calculated volumes (±S.E.M. of
four replicates) in the absence of nigericin were 1.604±0.0 to 2.02±0.02 µl per mg protein in 125 mM KCl and 50 mM KCl media respectively, whilst following the addition of 10 nM
nigericin the volumes decreased to 1.21±0.04 and 1.55±0.01 µl per mg protein respectively.
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increase intracellular [Ca2+] [18,21]. However, data from O'Rourke's
laboratory have suggested the presence of a third mechanism for
electrogenic K+ entry, a large conductance calcium-activated potas-
sium channel (mitoBKCa) that is blocked with charybdotoxin and
opened by NS1619. This may provide an alternative Ca2+-regulated
mechanism for matrix volume regulation [22]. Pharmacological data
has also implicated opening of this channel in IP [14,22–24] although
once again the speciﬁcity of the pharmacological interventions is open
to question [4].
Much of the evidence for the presence of mitoKATP channels comes
from studying the effects of pharmacological channel openers and
blockers on both isolated mitochondrial volume, measured by light
scattering, and potassium ﬂuxes in detergent-solubilised inner
membrane proteins reconstituted into proteoliposomes (see [5,6]).
However, we have questioned whether the reconstitution studies may
reﬂect contamination of mitochondria with plasma membranes [25].
Furthermore, data from our own and other laboratories [9,10,25] has
failed to provide any evidence for the activity of mitoKATP in intact
heart, liver or brain mitochondria. In this paper we have devised aFig. 2. The effects of nigericin and osmolarity on respiration by rat liver mitochondria. Rat liv
and B) or 50 mM KCl (panels C and D) and the respiratory substrate indicated G/M — 5 mM
indicated (+Nig) nigericin (10 nM) was added before mitochondria. The addition of ADP (200technique to quantify the potassium movements associated with the
small light-scattering changes induced by sub-nanomolar concentra-
tions of valinomycin and use these results to revisit the effects of
openers and blockers of mitoKATP and mitoBKCa on mitochondrial
potassium ﬂux. Our data provide no support for either of these chan-
nels mediating signiﬁcant potassium ﬂux or volume changes in liver
and heart mitochondria incubated under physiological conditions.
2. Materials and methods2.1. Materials
Valinomycin, nigericin, paxilline, cromakalim, diazoxide, 5-hydroxydecanoate
(5-HD), bovine serum albumin (BSA≥96% fatty acid free), NS1619 and all substrates
used for the oxygen electrode were from Sigma (Gillingham, Dorset, U.K.).
2.2. Isolation of liver and heart mitochondria
MaleWistar rats (250–275 g) were killed by cervical dislocation. The hearts or livers
were rapidly removed and placed in isolation buffer A (ISA) (300 mM sucrose, 10 mM
Tris–HCl, 2 mM EGTA, pH 7.4) to remove as much blood as possible. Heart tissue waser mitochondria were incubated in 1 ml buffer containing either 125 mM KCl (panels A
L-glutamate plus 2 mM L-malate; S/R — 5 mM succinate plus 200 nM rotenone. Where
µM) is marked by arrows. Data shown are typical of at least three separate experiments.
Fig. 3. Changes in the rate of respiration of rat liver and heart mitochondria induced by
increasing concentrations of valinomycin. Mitochondria from rat liver (panels A and B)
or heart (panel C) were incubated in 1 ml of either 50 mM KCl (panels A and C) or
100 mM sucrose (panel B) respiration buffer containing 1 µM oligomycin and nigericin
(10 and 1 nM for liver and heart mitochondria respectively) and 5 mM L-glutamate plus
2 mM L-malate. Rates of respiration were measured by linear regression of the trace
before and after addition (at the arrow) of valinomycin at the concentration shown.
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Nagarse (Bacterial Proteinase P8038 Sigma). For both tissues, homogenisation was
performed in ISA containing 0.5% (w/v) BSA (ISB) using a glass Dounce Potter
homogeniser and thereafter the preparation of mitochondria was performed by
differential centrifugation and Percoll gradient centrifugation as described previously
[9,26]. All procedures were performed at 4 °C and mitochondria were kept on ice until
use; this was always within 4 h of preparation. The protein concentration of
mitochondrial suspensions was determined using the biuret method [27]. In all oxygen
electrode and spectrophotometer experiments liver and heart mitochondria were used
at 2 and 1 mg protein/ml respectively.
2.3. Experimental buffers
All buffers for oxygen electrode and spectrophotometer experiments contained
20 mM MOPS, 10 mM Tris base, 2 mM phosphate (K- or Na-salt as required), 0.1 mM
sodium-EGTA and 1 mg/ml BSA (≥96% fatty acid free) and an osmotic support which
was either 125 mM KCl, 50 mM KCl (hypo-osmotic) or 100 mM sucrose (hypo-osmotic
potassium free). The pH was adjusted to pH 7.2 with KOH or Tris base (potassium free).
The hypo-osmotic media were employed to overcome the decrease in matrix volume
caused by nigericin addition and to ensure maximal rates of respiration [28,29]. Other
additions were made as required.
2.4. Oxygen electrode studies
The oxygen electrode (Hansatech Instruments Ltd.)was connected to a computer for
data recording and all experiments were performed at 30 °C in 1 ml of experimental
buffer containing either 5mM L-glutamate plus 2mM L-malate (G/M) or 5mM succinate
plus 200 nM rotenone (S/R) as respiratory substrate. Calibration was performed by
assuming that air-saturated KCl medium contains 225 nmol O2 per ml at 30 °C and zero
oxygen after dithionite addition.
2.5. Light-scattering and radio-isotope measurements of changes in mitochondrial matrix
volume
Light scattering was used to monitor matrix volume changes in real time and was
measured as the change in A520 as described previously [9]. Mitochondria were added
to 7 ml of the required buffer before apportioning 3.5 ml to both the sample and
reference cuvettes which were maintained at 30 °C with constant stirring to ensure
oxygenation. A520 was continuously recorded at 2 data points per second and additions
made through an injection port as required. In some experiments absolute determina-
tion of the matrix volume of mitochondria was made by measurement of the matrix
water content using 3H2O and [14C]-sucrose added directly to both reference and
sample cuvettes at the end of a run as described previously [9].
3. Results
3.1. Measurement of the rate of electrogenic K+ entry into the mitochondria
using an oxygen electrode
The addition of the K+/H+ exchanger, nigericin, to energised mito-
chondria will cause any K+ that enters the mitochondria electro-
genically through a K+ channel to leave the matrix again in exchange
for a proton. This stoichiometrically converts electrogenic K+ entry into
H+ entry, leading to a stimulation of respiration as these protons are
pumped back out to regenerate the protonmotive force. Since theH+:O
ratio is known to be 6 for succinate in the presence of rotenone and 10
for glutamate plus malate this allows the stimulation of the rate of
respiration mediated by the opening of a K+ channel to be converted
into the rate of K+ inﬂux. However, there is a problem associated with
this approach in that addition of nigericin to mitochondria causes loss
of endogenous K+ ions and shrinkage of themitochondrial matrix. This
is illustrated in panel A of Fig. 1 where increasing concentrations of
nigericin caused a progressive shrinkage of energised liver mitochon-
dria as reﬂected in an increase in light scattering (A520). This is likely to
cause an inhibition of respiration because the ﬂow of electrons from
complex I and complex II into complex III is strongly inhibited by a
decrease inmatrix volume [28,29]. The data of Fig. 2 conﬁrm that this is
the case for ADP-stimulated respiration of liver mitochondria in the
presence of glutamate plusmalate (panel A) or succinate plus rotenone
(panel B). In order to overcome this decrease in matrix volume, hypo-
osmoticmedia can be used as illustrated in the data of panels C andDof
Fig. 2. In parallel experiments reported in panel B of Fig. 1 we
determined matrix volume of rat liver mitochondria using 3H2O and[14C]-sucrose in the same mitochondrial samples used to determine
the decrease in light scattering induced by 10 nM nigericin. Liver
mitochondriawere incubated in both sample and reference cuvettes of
the spectrophotometer and then 10 nM nigericin added to the sample
cuvette. When the light-scattering signal had reached a new
equilibrium, 3H2O and [14C]-sucrose were added to both sample and
reference cuvettes for the determination ofmatrix volume. The resting
matrix volume (µl permgprotein±S.E.M. of 4 replicates) in the absence
of nigericin was determined as 1.60±0.02 in normal medium (iso-
osmotic — 125 mM KCl) whilst in hypo-osmotic medium (50 mM KCl)
the volume increased to 2.02±0.02. Following 10nMnigericin addition
the volumesdecreased to 1.21±0.04 and1.55±0.01 µl permgprotein in
the 125mMKCl and 50mMKCl media respectively. Importantly, these
data conﬁrm that the presence of nigericin in the 50 mM KCl medium
restored the volume to a similar value to that seen in the 125 mM KCl
medium in the absence of nigericin. For this reason, subsequent
experiments investigating the stimulation of respiration by valinomy-
cin in the presence of nigericin were performed in the 50 mM KCl
medium.
In Fig. 3 the effects of adding increasing concentrations of
valinomycin in the presence of nigericin on the rate of state 4
respiration are shown for liver (panels A and B) and heart (panel C)
Fig. 4. Quantiﬁcation of the ﬂux of K+ into mitochondria induced by increasing concentrations of valinomycin. Rates of state 4 respiration by rat liver (panels A and C) or heart (panels
B and D) mitochondria in the presence of 1 µM oligomycin and nigericin at 10 nM (liver) or 1 nM (heart) were determined as described in Fig. 3 both before and after addition of
valinomycin at the concentration shown. The respiratory substrate was either 5 mM L-glutamate plus 2 mM L-malate (G/M) or 5 mM succinate plus 200 nM rotenone (S/R) as
indicated. In panels C and D the valinomycin-induced increase in respiration was converted into ﬂuxes of K+ using an H+:O ratio of 10 or 6 for G/M or S/R respectively as explained in
the text. Data are given as means±S.E.M. (error bars) of 3 (liver) or 2 (heart) separate experiments each using a different mitochondrial preparation. In Fig. 6 panel D the data of
panel C are plotted against mean data for the changes in A520 induced by the same concentrations of valinomycin measured in parallel experiments.
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medium (panel A) was not observed in sucrose medium (panel B),
conﬁrming that it is potassium entry followed by K+/H+ exchange
that is leading to the stimulation of respiration. Fig. 4 shows the
mean data for the stimulation of respiration mediated by increasing
concentrations of valinomycin in liver (panel A) and heart (panel B)
mitochondria. Data are given for both glutamate plus malate and
succinate plus rotenone as substrate. In panels C and D the
valinomycin-induced increase in respiration (nmol min−1 per mg
protein) has been converted into ﬂuxes of K+ using an H+:O ratio of 10
or 6 for G/M or S/R respectively. This brings the data for both
substrates onto the same line, providing further conﬁrmation that
the stimulation of respiration is providing an accurate estimate of the
rate of K+ entry into the matrix.
3.2. The effects of valinomycin on light scattering and matrix volume
In parallel with measurements of the rate of K+ entry into
mitochondria induced by increasing concentrations of valinomycin
we monitored the light-scattering changes induced by valinomycin
under identical conditions and determined the increase in matrix
volume using 3H2O and [14C]-sucrose. These measurements provide
an indication of the sensitivity of light scattering as a technique for
measuring electrogenic K+ ﬂuxes. In Fig. 5 panel A we show the
increase in light scattering induced by 10 nM nigericin followed by the
subsequent decrease in light scattering upon progressive additions of
valinomycin. In Panel B we show the effects of the same concentra-
tions of valinomycin in the absence of nigericin. The responses in the
absence of nigericin are considerably larger than those observed in itspresencewhich provides good evidence that the nigericin is present at
high enough concentrations to facilitate loss of K+ from the matrix
almost as fast as it enters. In panel C we show that in sucrose medium
the nigericin gave the anticipated increase in light scattering as K+
leaves the matrix and mitochondria shrink, but that valinomycin gave
no compensating decrease in scattering since no external K+ was
available to enter. Panels D and E show similar data for the effects of
increasing concentrations of valinomycin on the light scattering of
heart mitochondria in the presence and absence of 1 nM nigericin
respectively. We found it necessary to use less nigericin for heart
mitochondria than liver mitochondria if we were not to reduce the
matrix volume too much and thus inhibit respiration. Since the
difference between the change in light scattering seen in the absence
and presence of nigericin is not great, it is clear that at 1 nM the
nigericin cannot exchange the K+ entering via valinomycin fast enough
to prevent some potassium accumulation and thus swelling. Conse-
quently, for the heart mitochondria experiments the increase in the
rate of respiration induced by valinomycin may underestimate the
rate of K+ ﬂux.
In the experiment shown in Fig. 6 panel A we used 3H2O and [14C]-
sucrose to determine the valinomycin-induced change in matrix
volume in the same liver mitochondrial samples used to monitor
changes in light scattering. The mitochondria were incubated in
50 mM KCl medium in the presence of 10 nM nigericin prior to adding
increasing concentrations of valinomycin to the sample cuvette and
then 3H2O and [14C]-sucrose added to both cuvettes for absolute
matrix volume determination. Panel B conﬁrms that no change in light
scattering occurred in response to valinomycin in potassium-free
(sucrose) medium. Panel C presents mean data from 3 similar
Fig. 5. The effects of nigericin and valinomycin on the light-scattering response of liver and heart mitochondria. Mitochondria from rat liver (panels A–C) or heart (panels D–E) were
incubatedwith continuous stirring in both sample and reference cuvettes of a split-beam spectrophotometer at 2mg and 1mg proteinperml respectively as described underMaterials
andmethods. The buffers usedwere 50mMKClmedium (panels A, B, D, and E) or 100mM sucrosemedium (panel C) containing 5mM succinate plus 200 nM rotenone (S/R) and 1 µM
oligomycin. Additions were made of nigericin (Nig) and valinomycin (Val) at the times and concentrations indicated.
Fig. 6. The relationship between the effects of valinomycin on light scattering, matrix volume and K+ ﬂux of rat liver mitochondria. Liver mitochondria were incubated in 50 mM KCl
medium (panel A) or 100mM sucrose medium (panel B) containing 10 nM nigericin and 1 µM oligomycin as described for Figs. 1 and 5 and additions of valinomycin (Val) made to the
sample cuvette at the times and concentrations indicated. At the end of the run (labelled isotope) 3H2O and [14C]-sucrose were added to both cuvettes and matrix volumes measured
as described for Fig. 1. Panel C shows the correlation between mean data (±S.E.M. — error bars) for the measured change in light scattering induced by increasing valinomycin
concentrations and the matrix volume from 3 separate experiments performed as in panel A. Panel D shows a similar correlation between mean data for the light scattering induced
by increasing valinomycin concentrations and the increase in K+ ﬂux taken from the experiments shown in Fig. 4 panel C.
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volume induced by valinomycin is plotted against the mean decrease
in light scattering induced by valinomycin in the same experiment. In
panel D of Fig. 6 we present the correlation between the decrease in
light scattering and the calculated rate of K+ ﬂux into mitochondria
presented in panel C of Fig. 4.
3.3. The effects of potassium channel openers and blockers on light
scattering and respiration of rat liver and heart mitochondria
Having established the sensitivity of the light scattering and
respiration techniques for measuring K+ ﬂux across the inner
mitochondrial membrane we used these techniques to determine
changes in K+ ﬂux induced by agents that have been reported to act as
openers or blockers of the putative mitoKATP and mitoBKCa channels.
The data of panels A and B of Fig. 7 conﬁrm our previous data [9] thatFig. 7. The effects of potassium channel openers and blockers on light scattering of rat liver an
using either 50 mM KCl or 100 mM sucrose buffer containing 5 mM L-glutamate plus 2 mM L
data obtained from 2 (heart) or 3 (liver) separate mitochondrial preparations that gave sim
openers (diazoxide, cromakalim) or blockers (5-HD) added at the concentrations and times sh
openers (NS1619) or blockers (paxilline). Note that for paxilline and NS1619 the decreases in
caused by K+ movements.neither diazoxide (30 or 50 µM) nor cromakalim (10, 20 or 30 µM), both
reported to be mitoKATP channel openers [5], cause any detectable
decrease in light scatteringof either liver orheartmitochondria. Nordid
5-hydroxydecanoate (100 or 200 µM), reported to be a mitoKATP
channel blocker [5], cause any detectable increase in light scattering. In
panels C–F of Fig. 7 we extend our investigations to NS1619 and
paxilline that have been reported to be openers and blockers re-
spectively of the putative mitoBKCa channel [22]. As might be predicted
for a K+ channel opener, we found that addition of increasing con-
centrations of NS1619 to either liver (panel C) or heart (panel D)
mitochondria caused a decrease in A520. However, we also show that
when the experimentswere repeated inK+-free sucrose buffer the same
decreases in A520 were observed. This implies that NS1619 is exerting a
non-speciﬁc effect unrelated to the opening of mitoBKCa channels. The
data of Fig. 8 panel A suggest that this non-speciﬁc effect may be due to
uncoupling of the mitochondria since increasing concentrations ofd heart mitochondria. The experimental protocol was the same as that described in Fig. 5
-malate as respiratory substrate and 1 µM oligomycin. Each panel shows representative
ilar results. Panels A and B represent typical traces revealing no effects of KATP channel
ownwhilst panels C and D represents typical traces revealing no effects of BKCa channel
light scattering observed were also seen in sucrose medium and thus are unlikely to be
Fig. 8. NS1619 and paxilline stimulate respiration by rat liver and heart mitochondria. Mitochondria were incubated in 1 ml 50 mM KCl respiration buffer containing 5 mM
L-glutamate plus 2 mM L-malate and 1 µM oligomycin. Additions of NS1619 or paxilline were made as indicated at the concentrations shown. The data presented are from a
single preparation each of rat heart (A) and liver (B) mitochondria.
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chondria even in the absence of nigericin. Similar non-speciﬁc effects
were observed with increasing concentrations of paxilline (10–50 µM)
which caused a decrease in A520 and not an increase as would be
expected for aK+ channel blocker (Fig. 7 panelD).Here too the paxilline-
induced decrease in A520 was also observed in K+-free sucrose medium
and oxygen electrode experiments suggested that slight uncoupling
was occurring (Fig. 8 panel B). In view of the non-speciﬁc uncoupling
effects of both paxilline and NS1619 on mitochondria, it is not possible
to assess whether these agents might also have exerted effects on a
mitoBKCa channel.
4. Discussion
4.1. The sensitivity of light-scattering measurements used to detect
modulation of mitochondrial K+ channel activity
Many laboratories have used light-scattering techniques to de-
tect changes in mitochondrial volume that accompany changes in
the permeability of the mitochondrial inner membrane to K+ (see
[3,5,9,10,25]). Using such techniques we [9] and others [10] were
unable to provide any evidence for a stimulation of K+ entry into heart,
liver or brain mitochondria by agents such as diazoxide, pinacidil or
cromakalim that others have reported to be openers of the putative
mitoKATP channel [5]. However, it couldbe argued that the changes inK+
ﬂux are too small to induce detectable changes in light scattering, so in
the present paper we have described a technique that allows an
approximate quantiﬁcation of the ﬂux of K+ that accompanies a
detectable change in A520. By incubating mitochondria in the presence
of nigericin the entry of K+ into mitochondria mediated by a K+ channel
is converted into a proton ﬂux that uncouples mitochondria as
illustrated for increasing concentrations of valinomycin in Fig. 3. From
the resulting stimulation of oxygen consumption the rate of K+ entry
can be calculated as is shown in Fig. 4. The lowest concentration of
valinomycin (0.1 nM) that gave a detectable stimulation of respiration
by liver mitochondria (2 mg per ml) was calculated to give a K+ ﬂux of
about 19.3±5.7 nmol per min per mg protein. This gave a readily
measurable increase in volume in the presence or absence of 10 nMnigericin (Fig. 5 panels A and B respectively) with the effect being at
least 5 times greater in the absence of nigericin where the compensa-
tory efﬂux of K+ is not stimulated. One caveat in relation to these
calculations is that endogenous proton leak increases steeply with
membrane potential [30]. Although any depolarisation caused by
0.1 nM valinomycin is likely to be very small, it could lead to a slight
underestimate of the proton inﬂux caused by potassium cycling. Thus
the absolute values calculated for K+ ﬂux must be regarded as approxi-
mate. Nevertheless, our data lead us to conclude that the light-
scattering technique is capable of detecting a stimulation of K+ inﬂux of
less than5nmol perminpermgprotein corresponding to an increase in
matrix volume of b2%.
4.2. Pharmacological agents provide no evidence for detectable activities
of mitoKATP and mitoBKCa channel in heart or liver mitochondria
Our inability to detect any change in light scattering by either KATP
channel openers such as diazoxide and cromakalim or blockers such
as 5-hydroxydecanoate or glibencamide (Fig. 7 and [9]) suggests that
the activity of these channels in rat liver and heart mitochondria in
vitro is likely to be very low (b5 nmol per min per mg protein) and
unable to produce any detectable change in volume or uncoupling.
Furthermore our data do not provide any evidence for the presence
of a mitoBKCa channel suggested by others [22]. Thus, although
NS1619, which is proposed to be an opener of this channel, induced a
decrease in A520 (Fig. 7 panel C) and a stimulation of oxygen
consumption (Fig. 8 panel A) this is unlikely to be due to K+ entry
because the same decrease in light scattering was seen in K+-free
sucrose medium. Uncoupling by NS1619 has also been described by
others [31,32] and it seems likely that the light-scattering effects of
NS1619 are the result of such uncoupling rather than the opening of
mitoBKCa channels. Furthermore, the proposed mitoBKCa channel
blocker paxilline produced a decrease in A520 rather than the
increase that might be expected (Fig. 7 panel D). This effect was
also seen in K+-free sucrose medium and was accompanied by
uncoupling (Fig. 8 panel B) implying that paxilline, like NS1619 and
some effectors of the putative mitoKATP channel [33,34] cannot be
used as speciﬁc pharmacological agents. However, our data do not
547P. Bednarczyk et al. / Biochimica et Biophysica Acta 1777 (2008) 540–548allow us to rule out totally the presence of a mitoBKCa channel
because the non-speciﬁc effects of NS1619 and paxilline may have
masked real effects on this channel activity.
4.3. Mitochondrial K+ channels are unlikely to mediate preconditioning
Although our data do not allow us to conclude that neither
mitoKATP nor mitoBKCa channels exist, they do suggest that their
activities are likely be too low to affect either matrix volume or
membrane potential (via K+-mediated uncoupling). Yet both an
increase inmatrix volume andmild uncoupling induced by K+ channel
opening have been proposed to mediate ischaemic preconditioning
(see [4,12,14,25]). Two mechanisms have been suggested by which
increase in matrix volume might offer protection; either through
stimulation of the respiratory chain and enhanced ATP production or
bybringing the inner and outermembranes closer together to allow for
more efﬁcient ATP export from themitochondria through contact sites
(see [12,25]). However, our inability to detect anychanges in volumeby
K+ channel openers described here (Fig. 7) and previously [9], and the
lack of correlation between cardioprotection and changes in matrix
volume determined in situ [8] make either of these possibilities
unlikely. Mild uncoupling of mitochondria by K+ channel openers has
been proposed to depolarise the mitochondria sufﬁciently during
reperfusion to reduce ROS production and calcium accumulation and
hence prevent the opening of the mitochondrial permeability transi-
tion pore. However, as argued by others [35,36] and by our own data
presented here, the rate of K+ entry through K+ channels would be too
low to cause signiﬁcant uncoupling. Furthermore, direct measure-
ments of mitochondrial membrane potential failed to detect any
depolarisation [37,38]. Moreover, there is evidence that diazoxide can
enhance ROS production independently of mitoKATP channel opening,
perhaps through its well documented inhibition of the respiratory
chain [39].
4.4. Mitochondrial KATP and BKCa channel openers may precondition
independently of channel opening
There is increasing evidence that the supposed ‘speciﬁc’ mito-
chondrial K+ channel openers have other non-speciﬁc effects on
mitochondrial function, including uncoupling [7,33,34,40] and
inhibition of complex I and complex II of the respiratory chain
[7,8,36,39,41–42]. These non-speciﬁc effects may actually be the
mechanism by which preconditioning is exerted rather than through
K+ channel opening. Thus it is known that adding low doses of
uncoupler prior to ischaemia can precondition hearts [43,44]. Fur-
thermore, any interference with oxidative phosphorylation during
the preischaemic phase seems able to exert a similar protective effect
including the addition of a respiratory chain inhibitor [45–48] or a
succinate dehydrogenase inhibitor [49]. How thismight be translated
into a protective effect at reperfusion is not clear, although some
respiratory chain inhibitors have been reported to increase ROS
production in isolated cardiac myocytes [39,45,50] as have low doses
of uncoupler [44]. Since ROS can activate protein kinase C (PKC)
which is known to be important in preconditioning (see [25,51]) this
may provide a mechanism for the preconditioning effect. Indeed, the
protective effects of diazoxide and nicorandil can be overcome by
free radical scavengers such as N-(2-mercaptopropionyl) glycine
[4,39,52,53]. Furthermore, in the case of the established respira-
tory chain inhibitor, antimycin, cardioprotection is abolished in PKCε
knockout mice [50].
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